Literature DB >> 31085912

Digoxin Attenuates Receptor Activation of NF-κB Ligand-Induced Osteoclastogenesis in Macrophages.

Kimihiro Igari1, Matthew J Kelly1, Dai Yamanouchi2.   

Abstract

BACKGROUND: Even though hypoxia-inducible factor-1α (HIF-1α) is among the transcriptional factors demonstrated to contribute to the formation of abdominal aortic aneurysms (AAAs), the precise mechanism has been unclear. Digoxin is known as an inhibitor of HIF-1α, and shows a protective effect against the progression of AAAs.
OBJECTIVES: We tested the effect of digoxin on osteoclastogenesis (OCG) and examined the pathway through which digoxin exerts inhibition of HIF-1α.
MATERIALS AND METHODS: RAW 264.7 macrophage cells were cultured and stimulated by soluble receptor activator of NF-κB ligand (sRANKL) with or without digoxin. First, we tested the effect of digoxin to attenuate macrophage activation, which led to OCG, characterized by tartrate-resistant acid phosphatase (TRAP)-positive macrophages (TPMs).
RESULTS: The activation of TPMs stimulated by sRANKL was attenuated by digoxin treatment. Furthermore, the receptor activator of NF-κB (RANK)/receptor activator of NF-κB ligand (RANKL) complex signaling pathway, which is stimulated by HIF-1α, was downregulated by digoxin treatment.
CONCLUSIONS: These results show that digoxin attenuates OCG. By inhibition of HIF-1α, digoxin decreases OCG through the downregulation of the RANK/RANKL signaling pathway. Therefore, digoxin is a potential candidate for medical treatment of AAAs.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Aneurysm; Digoxin; Hypoxia-inducible factor-1α; Macrophage; Osteoclastogenesis

Mesh:

Substances:

Year:  2019        PMID: 31085912      PMCID: PMC6764455          DOI: 10.1159/000499380

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  33 in total

1.  Hypoxia at the site of abdominal aortic aneurysm rupture is not associated with increased lactate.

Authors:  Edward Choke; Gillian W Cockerill; Joseph Dawson; Yuen-Li Chung; John Griffiths; Richard W Wilson; Ian M Loftus; Matthew M Thompson
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

Review 2.  Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services Task Force.

Authors:  Craig Fleming; Evelyn P Whitlock; Tracy L Beil; Frank A Lederle
Journal:  Ann Intern Med       Date:  2005-02-01       Impact factor: 25.391

Review 3.  Hypoxia-inducible factor-1 in arterial disease: a putative therapeutic target.

Authors:  Veeru Kasivisvanathan; Joseph Shalhoub; Chung S Lim; Amanda C Shepherd; Ankur Thapar; Alun H Davies
Journal:  Curr Vasc Pharmacol       Date:  2011-05       Impact factor: 2.719

4.  JNK2 up-regulates hypoxia-inducible factors and contributes to hypoxia-induced erythropoiesis and pulmonary hypertension.

Authors:  Marc A Sala; Cong Chen; Qiao Zhang; Hanh Chi Do-Umehara; Wenjiao Wu; Alexander V Misharin; Gregory B Waypa; Deyu Fang; G R Scott Budinger; Shuwen Liu; Navdeep S Chandel; Paul T Schumacker; Jacob I Sznajder; Jing Liu
Journal:  J Biol Chem       Date:  2017-11-08       Impact factor: 5.157

5.  Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation.

Authors:  William F Johnston; Morgan Salmon; Gang Su; Guanyi Lu; Matthew L Stone; Yunge Zhao; Gary K Owens; Gilbert R Upchurch; Gorav Ailawadi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

6.  No adaptation to digitalization as evaluated by digitalis receptor (Na,K-ATPase) quantification in explanted hearts from donors without heart disease and from digitalized recipients with end-stage heart failure.

Authors:  T A Schmidt; P D Allen; W S Colucci; J D Marsh; K Kjeldsen
Journal:  Am J Cardiol       Date:  1993-01-01       Impact factor: 2.778

7.  Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease.

Authors:  Wei Wang; Baohui Xu; Haojun Xuan; Yingbin Ge; Yan Wang; Lixin Wang; Jianhua Huang; Weiguo Fu; Sara A Michie; Ronald L Dalman
Journal:  J Vasc Surg       Date:  2017-12-11       Impact factor: 4.268

8.  Effect of digoxin on experimental adrenaline-induced hyperglycemia and insulin-induced hypoglycemia.

Authors:  E Krusteva
Journal:  Folia Med (Plovdiv)       Date:  1992

9.  Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth.

Authors:  Huafeng Zhang; David Z Qian; Yee Sun Tan; Kangae Lee; Ping Gao; Yunzhao R Ren; Sergio Rey; Hans Hammers; Daniel Chang; Roberto Pili; Chi V Dang; Jun O Liu; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-19       Impact factor: 11.205

10.  RANKL-mediated osteoclastogenic differentiation of macrophages in the abdominal aorta of angiotensin II-infused apolipoprotein E knockout mice.

Authors:  Teruyoshi Tanaka; Matthew Kelly; Yuichiro Takei; Dai Yamanouchi
Journal:  J Vasc Surg       Date:  2018-04-21       Impact factor: 4.268

View more
  2 in total

1.  Distinct roles for the hypoxia-inducible transcription factors HIF-1α and HIF-2α in human osteoclast formation and function.

Authors:  Helen J Knowles
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

2.  Osteoclast-Like Cells in Aneurysmal Disease Exhibit an Enhanced Proteolytic Phenotype.

Authors:  Matthew J Kelly; Kimihiro Igari; Dai Yamanouchi
Journal:  Int J Mol Sci       Date:  2019-09-21       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.